| Autor: |
J Melhorn, Samer Elkhodair, Ruth Knight, Phil Moss, Jonathan Underwood, A Wang, Vicki S Barber, M Jabeen, Susan J Dutton, Tanya Baron, Lucy Cureton, Daniel Lasserson, Sophie B. Morgan, Jennifer L Cane, David Clarke, Duncan Richards, Rajendar Garlapati, Hinks Tsc., Ian D. Pavord, Joanna Black, Fleur Cantle, Graham Johnson |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Developing treatments for COVID-19. |
| Popis: |
Background The antibacterial, anti-inflammatory and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease are lacking. We assessed whether azithromycin is effective in reducing hospitalisation in patients with mild-moderate COVID-19. Methods This open-label, randomised superiority clinical trial at 19 centres in the United Kingdom enrolled adults, ≥18 years, presenting to hospitals with clinically-diagnosed highly-probable or confirmed COVID-19 infection, with |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
